Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880932 · ClinicalTrials.gov registry record · NA
Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,865
- Enrollment target
NCT00880932: Completed NA study, sponsored by University of Pennsylvania.
NCT00880932 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,865 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00880932, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,865 participants
- Enrollment target
Study Summary
The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.
Interventions
- BEHAVIORAL Electronic Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,865 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-12 |
| Phase | NA |
What the finished NCT00880932 record still lists
NCT00880932 is an interventional study that assigns participants to a tested intervention. Its 1,865 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which Electronic Alert is the first listed.
NCT00880932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00880932 about?
NCT00880932 is a clinical study titled "Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert". The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribe...
What is the current status of trial NCT00880932?
This trial is currently completed. It is a NA study. The enrollment target is 1,865 participants. The study started on 2006-08. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00880932?
The interventions under investigation include: Electronic Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT00880932?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00880932's enrollment target sits among peer trials
1,865 56th of 2000 higher than 1,945 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07203313 · 1,872 participants · NA
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia